OpenEvidence vs DynaMed Decisions

Direct competitors — feature-level head-to-head below. Comparability 85/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by OpenEvidence
VS
by EBSCO Information Services

AI Verdict

OpenEvidence and DynaMed Decisions are direct competitors in the clinical decision support space, both aiming to enhance clinical decision-making for healthcare professionals. OpenEvidence leverages AI for rapid, referenced answers from a vast medical literature database and offers AI-powered clinical documentation, while DynaMed Decisions focuses on individualized clinical guidance, risk calculators, and patient decision aids to drive patient engagement. The primary distinction lies in OpenEvidence's AI-first approach to evidence synthesis and documentation versus DynaMed Decisions' emphasis on structured, individualized guidance and patient shared decision-making tools.

Choose OpenEvidence if…

Choose OpenEvidence if you are a verified U.S. healthcare professional seeking immediate, referenced answers to clinical questions directly from peer-reviewed medical literature. It's particularly well-suited for quickly finding evidence-based treatment options, cross-checking decisions against guidelines, and assisting with clinical documentation and administrative tasks like drafting prior authorization letters.

View OpenEvidence →

Choose DynaMed Decisions if…

Choose DynaMed Decisions if your priority is individualized clinical guidance, risk calculators, and patient decision aids to enhance shared decision-making and patient engagement. This tool is ideal for clinicians who want to provide personalized care based on specific patient characteristics and preferences, and for institutions looking to streamline workflows with interactive, evidence-based recommendations.

View DynaMed Decisions →

When choosing between OpenEvidence and DynaMed Decisions, physicians should consider their primary needs: rapid, evidence-based answers and documentation support versus individualized patient guidance and shared decision-making tools. Both platforms offer robust clinical decision support, but their core strengths cater to different aspects of the clinical workflow.

OpenEvidence excels at providing immediate, referenced answers to clinical questions directly from peer-reviewed literature and streamlining documentation through AI-powered transcription and note generation. It is particularly well-suited for physicians who prioritize quick access to medical evidence at the point of care and desire integrated tools to reduce the burden of clinical documentation. Its free access for verified U.S. healthcare professionals makes it an accessible option for individual practitioners.

DynaMed Decisions, on the other hand, focuses on individualized clinical guidance, risk calculators, and patient decision aids (Option Grid). This makes it ideal for physicians who frequently engage in shared decision-making with patients and require tools to personalize care recommendations based on specific patient characteristics. While pricing is not publicly disclosed, its emphasis on patient engagement and tailored guidance distinguishes it for practices aiming to enhance patient involvement in treatment plans.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature OpenEvidence DynaMed Decisions
Pricing Free Contact for pricing
Deployment Cloud-based (web application) and mobile applications Web-based, EHR integration (SMART on FHIR, HL7 Infobutton API, full API integration), mobile app access.
FDA Status Unknown Not applicable AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

OpenEvidence

OpenEvidence is highly praised for its fast, clear, and succinct answers, with a conversational interface that mimics a senior colleague. It is available as a web application and mobile apps, with a focused interface that excels at providing quick, cited answers to clinical questions. DynaMed Decisions also offers interactive tools and evidence-based recommendations to streamline workflows, but user reviews for its related product, DynaMed, indicate a mixed experience, with some finding it easy to navigate and others preferring the layout of competitors.

Clinical Value

OpenEvidence

OpenEvidence provides AI-powered natural language question answering with answers grounded in peer-reviewed medical evidence from reputable sources like NEJM, JAMA, NCCN, and Cochrane, with transparent sourcing. It also offers OpenEvidence Visits for transcribing patient visits and auto-generating structured medical notes. While DynaMed Decisions offers individualized clinical guidance, risk calculators, and patient decision aids, it explicitly states that it currently does not employ AI in its tools, relying instead on peer-reviewed predictive models.

Pricing & Value

OpenEvidence

OpenEvidence is free for verified U.S. healthcare professionals, funded by pharmaceutical advertising, making it a highly accessible option. Enterprise pricing is available for EHR integration and data insights. DynaMed Decisions requires separate licensing and does not publicly disclose its pricing, though its related product, DynaMed, starts from $399/year.

Enterprise Readiness

OpenEvidence

OpenEvidence has demonstrated significant enterprise readiness through its integration with EHR systems like Epic at Mount Sinai Health System and its rapid adoption by over 40% of U.S. physicians across more than 10,000 hospitals. It also offers enterprise pricing models for EHR integration and data insights. DynaMed Decisions offers EHR integration via SMART on FHIR, HL7 Infobutton API, and full API integration, and has a BAA, indicating readiness for enterprise deployment. However, specific large-scale adoption or integration examples are not as prominently highlighted as for OpenEvidence.

Innovation

OpenEvidence

OpenEvidence leverages AI-powered natural language processing to provide immediate, referenced answers from a vast array of peer-reviewed medical literature and offers AI-powered ambient documentation. This direct application of generative AI for clinical queries and documentation is a significant innovation in the CDS space. DynaMed Decisions focuses on individualized clinical guidance, risk calculators, and patient decision aids, but explicitly states it does not currently use AI in its tools, relying on established predictive models.

Support & Docs

Tie

Both tools are designed for healthcare professionals and are backed by reputable companies (OpenEvidence by OpenEvidence, DynaMed Decisions by EBSCO Information Services). Both platforms emphasize evidence-based methodologies and transparent sourcing. However, specific details regarding the depth and accessibility of their support channels or documentation (e.g., user guides, dedicated support teams, community forums) are not extensively detailed in the provided information or readily available through general web searches for a direct comparison.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature OpenEvidence DynaMed Decisions
Name OpenEvidence DynaMed Decisions
Company OpenEvidence EBSCO Information Services
Tagline America's Official Medical Knowledge Platform An advanced clinical decision support solution providing individualized clinical guidance, risk calculators, and patient decision aids for personalized care.
Categories Clinical Decision Support & Reference, Documentation & Scribing Clinical Decision Support & Reference, Patient Engagement & Education
Key Features (selection) AI-powered natural language question answering, answers grounded in peer-reviewed medical evidence (NEJM, JAMA, NCCN, Cochrane, PubMed), OpenEvidence Visits (transcribe patient visits and auto-generate structured medical notes), real-time clinical decision support integrated into documentation workflows, integrates with EHR systems like Epic Individualized clinical guidance, risk calculators, patient decision aids (Option Grid), enhances clinical decision-making, decreases burden on providers, drives meaningful patient engagement, interactive tools and evidence-based recommendations, streamlines clinical workflows
AI Usage AI-powered natural language question answering, AI-powered ambient documentation (OpenEvidence Visits), AI-integrated dialer feature Currently, DynaMed Decisions does not employ AI in its tools, but emphasizes algorithm transparency and exclusively uses peer-reviewed predictive models. The related product, DynaMed, offers Dyna AI.

Videos

Demos, reviews, and walkthroughs featuring OpenEvidence and DynaMed Decisions.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

OpenEvidence offers integration with EHR systems like Epic and provides real-time clinical decision support directly within documentation workflows. DynaMed Decisions supports EHR integration via SMART on FHIR, HL7 Infobutton API, and full API integration, aiming to streamline clinical workflows and provide individualized guidance.
OpenEvidence leverages AI to provide immediate, referenced answers grounded in peer-reviewed medical literature from sources like NEJM and JAMA, with transparent sourcing. DynaMed Decisions focuses on individualized clinical guidance, risk calculators, and patient decision aids to enhance decision-making based on patient specifics, though its specific evidence grounding methodology is less detailed in the provided information.
Both OpenEvidence and DynaMed Decisions list Internal Medicine as a supported specialty. OpenEvidence emphasizes AI-powered natural language querying and documentation tools, while DynaMed Decisions highlights individualized guidance, risk calculators, and patient decision aids for personalized care, which may appeal differently depending on your specific practice focus within Internal Medicine.
OpenEvidence is a web and mobile application, suggesting a potentially intuitive interface, and is free for verified U.S. healthcare professionals, which might ease initial adoption. DynaMed Decisions is also web-based with mobile access and aims to decrease provider burden, implying ease of use. For multi-site rollouts, OpenEvidence offers enterprise pricing models for EHR integration, while DynaMed Decisions' enterprise support would need to be discussed directly with EBSCO Information Services.
While both tools are HIPAA compliant and offer BAAs, the provided information does not detail specific security features beyond compliance or explicit audit-trail capabilities. Further inquiry would be needed to understand their data integrity and accountability measures.
OpenEvidence, being free for verified U.S. healthcare professionals, offers immediate value in terms of access to referenced medical knowledge and documentation tools without direct cost. DynaMed Decisions aims to decrease provider burden and drive meaningful patient engagement, suggesting efficiency gains and improved outcomes, but specific time-to-value would depend on integration depth and adoption within your practice.

Backers

Who funded each tool's parent company.

OpenEvidence

AI Tool Finder
AI-powered search. Results may not be comprehensive.